Management of Atrial Fibrillation with Rapid Ventricular Response

Spontaneous Conversion Rates

• Some patients with atrial fibrillation with rapid ventricular response (AFib with RVR) may revert spontaneously to sinus rhythm during follow-up, particularly in postoperative settings, as acknowledged by the European Society of Cardiology 1
• Management decisions should be made based on the assumption that most patients will require intervention rather than waiting for spontaneous conversion, according to the American College of Cardiology 2, 3

Factors Affecting Self-Conversion

• Patients with paroxysmal AFib, especially younger individuals with minimal underlying heart disease, are more likely to spontaneously convert than those with persistent AFib, as reported by the American College of Cardiology 4, 5
• Postoperative AFib has a higher likelihood of spontaneous conversion compared to other forms of AFib, as noted by the European Society of Cardiology 1

Management Approach

Immediate Management for Hemodynamically Unstable Patients

• Synchronized direct current electrical cardioversion is recommended for patients who are hemodynamically unstable with AFib and RVR, as advised by the European Society of Cardiology and the American Heart Association 1, 6
• Cardioversion is particularly indicated when AFib with RVR is associated with symptomatic hypotension, angina, or heart failure, according to the American Heart Association 7, 8

Rate Control for Hemodynamically Stable Patients

• For hemodynamically stable patients, rate control medications should be initiated promptly rather than waiting for spontaneous conversion, as recommended by the American College of Cardiology and the American Heart Association 2, 7
• First-line agents for rate control include beta-blockers (e.g., metoprolol, esmolol) and non-dihydropyridine calcium channel blockers (diltiazem, verapamil), as suggested by the European Society of Cardiology 9, 10

Special Considerations

• In patients with Wolff-Parkinson-White syndrome and pre-excited AFib with RVR, IV procainamide or ibutilide is recommended rather than AV nodal blocking agents, as advised by the American College of Cardiology and the European Society of Cardiology 2, 9
• In patients with heart failure and AFib with RVR, beta-blockers should be used with caution, and amiodarone may be preferred, according to the American College of Cardiology 2

Long-Term Management

• A lenient heart rate control target of <110 bpm at rest may be considered as the initial goal, as suggested by the European Society of Cardiology 1
• For patients with recurrent or refractory AFib with RVR, rhythm control strategies including antiarrhythmic medications, cardioversion, or catheter ablation should be considered, as recommended by the European Society of Cardiology 1